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INTRODUCTION
Feline hemotropic mycoplasmosis (FHM) is the
new name given to the disease formerly known as fe-
line infectious anemia or hemobartonellosis (Sykes,
2003). The causative agents of this disease are hemo-
tropic mycoplasmas (hemoplasmas). So far, three fe-
line hemoplasma species have been described:
Mycoplasma haemofelis (M. haemofelis), “Candida-
tus Mycoplasma haemominutum” (“Candidatus M.
haemominutum”) and “Candidatus Mycoplasma turi-
censis” (“Candidatus M. turicensis”) (Neimark et al.,
2001, 2002; Foley and Pedersen, 2001; Willi et al.,
2005). 
This case report describes a young male cat with
pure red cell aplasia. An acute infection with “Candi-
datus M. haemominutum” could have contributed to
an immune-mediated pure red cell aplasia. 
CASE REPORT
A five-month-old intact male Felis vulgaris was
brought to the referring veterinarian, with lethargy
being the main complaint. His mucous membranes
(mouth and eyes) were very pale. The cat was mostly
kept indoors, together with another healthy cat, and
was regularly vaccinated (Purevax RCPCh®, Merial)
and dewormed (Catminth®, Pfizer Animal Health).
Hemotropic mycoplasmas in cats
Part 2: case report
Hemotrofe mycoplasmen bij katten
Deel 2: casuïstiek
1M.B. Duin, 1H. Moyaert, 2I. Van de Maele, 2S. Daminet, 1F. Boyen
1 Department of Pathology, Bacteriology and Avian Diseases, 
Faculty of Veterinary Medicine, Ghent University, 
Salisburylaan 133, B-9820 Merelbeke, Belgium 
2 Department of Medicine and Clinical Biology of Small Animals,
Faculty of Veterinary Medicine, Ghent University, 
Salisburylaan 133, B-9820 Merelbeke, Belgium
filip.boyen@ugent.be
ABSTRACT
An eight-month-old apathic cat was referred to the Department of Medicine and Clinical Biology of Small
Animals of the Ghent University Faculty of Veterinary Medicine, Merelbeke, Belgium. The cat had a severe
case of non-regenerative anemia with a hematocrit of only 2.9%. Cytological examination of a bone marrow
aspirate led to the diagnosis of pure red cell aplasia (PRCA). Additionally, a PCR assay for “Candidatus My-
coplasma haemominutum” (“Candidatus M. haemominutum”) DNA was positive. Although unproven, an in-
fection with “Candidatus M. haemominutum” could have contributed to the immune-mediated destruction of
red blood cell precursors. The cat recovered completely after treatment, which consisted of multiple blood
transfusions, antimicrobial agents, and long-term prednisolone therapy (10 months). There were no signs of
clinical relapse at 20 months after cessation of therapy. 
SAMENVATTING
Een acht maanden oude kat werd in apatische toestand doorverwezen naar de vakgroep Geneeskunde en
Klinische Biologie van de Kleine Huisdieren van de Faculteit Diergeneeskunde in Merelbeke, België. De kat had een
erge niet-regeneratieve anemie met een hematocriet van slechts 2,9%. Het cytologisch onderzoek van een beenmerg -
aspiraat leidde tot de diagnose van “pure red cell aplasia” (PRCA). Daarnaast was een PCR (polymerase chain
reaction)-test voor “Candidatus Mycoplasma haemominutum” DNA positief. Hoewel niet bewezen, zou de infectie
met “Candidatus M. haemominutum” kunnen bijgedragen hebben tot een immuungemedieerde vernietiging van de
rode bloedcelprecursoren. Na een langdurige prednisolonebehandeling (10 maanden), meerdere bloedtransfusies en
een antimicrobiële therapie was de kat volledig hersteld. Twintig maanden na de stopzetting van de therapie waren
er nog steeds geen tekenen van klinisch herval. 
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Blood analysis was performed and included complete
blood count (CBC), biochemistry and viral serology.
The results revealed severe microcytic, normochromic
anemia and mild lymphocytosis. The serological tests
for Feline Leukemia Virus (FeLV), Feline Immunode-
ficiency Virus (FIV) and Feline Coronavirus were ne-
gative. A detailed overview of the blood test results is
presented in Table 1. The cat was treated with predni-
solone injections 6.25 mg/kg (Prednisolone® 2.5%,
Kela, Hoogstraten, Belgium) SC, SID, over a period
of seven days. Thereafter, five days of methyl pred -
nisolone 1 mg/kg (Moderin® 2 mg, Pfizer Animal
Health, Louvain-la-Neuve, Belgium) PO, SID was
given. This led to clinical improvement and the pale
mucous membranes turned pink again. Two months
later, the cat gradually became lethargic again and 0.5
mg/kg methylprednisolone (Moderin® 2 mg, Pfizer
Animal Health) was administered PO every other day.
Its clinical condition slowly deteriorated: the lethargy
worsened, the mucous membranes became pale again
and the cat developed anorexia. A blood analysis at
that time revealed a more severe microcytic anemia.
The reticulocyte percentage was mildly increased. Fur-
thermore, there were increased serum iron and serum
urea concentrations, as well as increased liver enzyme
activity (aspartate aminotransferase (AST) and alanine
aminotransferase (ALT)) and hypokalemia (Table 1).
Microscopic examination of a blood smear showed no
signs of infection with hemoplasmas, Babesia species
or heartworm (Dirofilaria immitis). On the same day,
the cat was referred to the Department of Medicine and
Clinical Biology of Small Animals of the Ghent Uni-
versity Faculty of Veterinary Medicine, Merelbeke,
Belgium for further examination and treatment. Phy-
sical examination showed that the animal was apathic
and in poor nutritional condition (2.150 kg body-
weight). The cat was hypothermic (rectal temperature
35.0° C), the mucous membranes were very pale, and
the capillary refill time could not be determined. There
were no other remarkable findings on physical exami-
nation. CBC, serum sodium and potassium concentra-
tions (Table 2), as well as the SNAP® Combo Plus FIV
antibody/FeLV antigen test kit, (IDEXX Laboratories,
Maine, USA) and a blood smear were all repeated
(Table 2). Additionally, a high specificity real-time
PCR assay (Scanelis, Toulouse, France) for Myco-
plasma haemofelis and “Candidatus Mycoplasma
haemo minutum” was performed. The results of the
SNAP® test were negative. On the blood smear, plate-
let aggregates were visible and there was anisocytosis
and polychromasia of the erythrocytes. Autoaggluti-
nation was negative and a direct Coombs test could not
be performed due to an insufficient blood sample. 
After blood typing (type A blood), a transfusion of
fresh whole blood was started, followed by an intra-
venous infusion of NaCl 0.9%, and the cat was war-
med with an infrared light. After the transfusion, the
hematocrit increased to 10% (reference range 25-45%)
and the clinical condition improved. Subsequently,
thoracic radiographs and abdominal ultrasonography
Table 1. Results of the first two blood tests.
02 Oct 2006 08 Jan 2007 Reference ranges Units
Hematology
Hemoglobin 1.56 0.75 4.98-9.34 mmol/L
Hematocrit 6.9 2.9 24.0-45.0 %
Erythrocytes 1.94 1.08 5.00-10.00 1012/L
MCV 35.8 26.5 37.0-55.0 fL
MCH 12.8 11.5 12.0-18.0 pg
MCHC 35.7 43.2 30.0-36.0 g/dL
Leukocytes 14630 8030 5000-15000 /µL
Total immature neutrophils 0 0 < 550 106/L
Total segmented neutrophils 7096 4958 3600-10500 106/L
Total lymphocytes 5647 2987 900-4200 106/L
Total monocytes 410 137 < 550 106/L
Total basophils 15 0 0-80 106/L
Total eosinophils 1448 32 < 800 106/L
Platelets 458000 320000 175000-500000 /µL
Reticulocytes nd 2.1 < 1.3 %
Iron nd 278 110-170 µg/dL
Biochemistry
Sodium nd 156 145-158 mmol/L
Potassium nd 2.6 3.0-5.0 mmol/L
Urea 12.32 26.97 6.66-11.65 mmol/L
Creatinine 69 87.5 8.8-132.6 µmol/L
Total proteins 65 74 56-78 g/L
Albumin 34.8 43.7 25.0-45.0 g/L
Total bilirubin 0.10 < 0.10 < 0.40 mg/dL
AST 33 170 < 46 U/L
ALT 57 214 < 43 U/L
Gamma-glutamyltransferase < 3 < 3 < 9 U/L
nd= not determined
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were performed to identify underlying causes. The tho-
racic radiographs showed signs of left-sided heart di-
latation, and abdominal ultrasonography showed a
liver with homogeneous parenchyma displaying the
presence of congestive vasculature. Echocardiography
did not reveal any structural abnormalities of the heart. 
The most important differentials at this time were
infectious causes, immune-mediated causes or a pri-
mary bone marrow disorder. Therefore, doxycycline
10 mg/kg (Ronaxan® 20, Merial Belgium, Toulouse,
France) PO, SID (together with food) and predniso-
lone 1 mg/kg (Prednisolone® 5 mg, Kela, Hoogstraten,
Belgium) PO, BID were prescribed. Further, ranitidine
2 mg/kg (Zantac®, GlaxoSmithKline, Genval, Bel-
gium) IV, BID, was prescribed. The CBC and serum
sodium and potassium concentrations were followed
daily (Table 2).
On the 4th day of hospitalization, the NaCl infusion
was removed because the cat started to eat inde -
pendently, and as from then ranitidine was given PO
(Zantac® syrup, GlaxoSmithKline). The prednisolone
dose was increased to 1.75 mg/kg PO, BID. Potassium
gluconate 2 mEq K+ (Ultra-K® syrup, 20 mEq K+/15
ml, Melisana, Turnhout, Belgium), PO, BID was
supplemented because of hypokalemia. The result of
the PCR test for hemoplasmas was available on day 5
and the cat was found to be positive for “Candidatus
M. haemominutum” DNA. On the 8th day of
hospitalization, a second transfusion of fresh whole
blood was administered and a bone marrow aspiration
was performed under superficial general anesthesia
(buprenorphine 0.01 mg/kg IV (Temgesic®, Schering-
Plough, Hull, United Kingdom), propofol 2 mg/kg IV
(Rapinovet®, Schering-Plough, Wicklow, Ireland). On
cytological examination of the aspirate, various
megakaryocytes were visible. There was erythrocytic
aplasia (myeloid-to-erythroid ratio > 75:1) and a mild
to moderate granulocytic hypoplasia. Based on the
bone marrow specimen, pure red cell aplasia (PRCA)
was diagnosed. The bone marrow aspirate was tested
with a PCR assay for FeLV, but the result was
negative. On day 9, the hematocrit had returned to
reference ranges and the cat was sent home. The
following treatment was continued at home: ranitidine
2 mg/kg (Zantac® syrup) PO, BID, 30 minutes before
the meal, doxycycline 10 mg/kg (Ronaxan® 20) PO,
SID (together with food) and prednisolone 1.75 mg/kg
(Prednisolone® 5 mg) PO, BID.
Two weeks later, the cat was alert and had gained
weight (bodyweight 2.25 kg). The hematocrit at that
time was 20.3%, with a normal reticulocyte percen-
tage (1.1%; reference range <1.3%). There was a leu-
kopenia (2720 /μL; reference range 5000-15000 /μL)
with a decrease in the number of segmented neutro-
phils (1707 x 106/L; reference 3600-10500 x 106/L).
Treatment with ranitidine and doxycycline was dis-
continued, but prednisolone 1.7 mg/kg (Prednisolone®
5 mg) PO, BID, was further administered. A second
bone marrow punction was recommended if the
leuko penia would persist. 
The dosage of prednisolone was slowly tapered
over the succesive 10 months and was then disconti-
nued. Twenty months after diagnosis, the cat is in good
health and the results of CBCs, performed on a regu-
lar basis, are within reference ranges.
DISCUSSION
The cat in this report presented with severe micro-
cytic anemia. The reticulocyte percentage was mildly
increased, but the regeneration was highly insufficient
in relation to the extremely low hematocrit. The cat
was therefore diagnosed with a non-regenerative ane-
mia. The major differential diagnosis of non-regene-
rative anemia in cats are bone marrow disorders,
infectious diseases, anemia due to chronic disease,
Table 2. Results of the blood analyses performed during hospitalization (08 Jan 2007 (day 1 of hospitalization) until
16 Jan 2007 (day 9 of hospitalization)). 
08 Jan 09 Jan 10 Jan 11 Jan 12 Jan 13 Jan 14 Jan 16 Jan Reference 
day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 9 ranges Units
Hematology
Leukocytes 7.1 5.5 6.1 7.3 7.6 7.3 10.2 5.6 6.0-11.0 109/L
Erythrocytes 1.08 3.55 2.40 2.19 2.27 1.93 1.85 8.78 5.00-10.00 1012/L
Hemoglobin 0.0 3.2 2.4 2.1 2.1 1.8 1.8 6.7 5.0-9.3 mmol/L
Hematocrit 4.0 16.0 10.8 9.8 10.3 8.9 8.7 36.8 25.0-45.0 %
Platelets 278 477 271 246 198 205 195 749 180-550 109/L
MCV 37 45 45 45 45 46 47 42 40-55 fL
MCH 0.00 0.91 0.98 0.96 0.94 0.94 0.96 0.76 0.81-1.05 fmol
MCHC 0.0 20.2 21.9 21.3 20.7 20.3 20.3 18.1 19.2-22.3 mmol/L
# lymphocytes 2.3 2.2 2.9 3.0 2.8 3.3 4.1 1.6 1.2-3.2 109/L
# monocytes 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3-0.8 109/L
# granulocytes 4.8 3.3 3.2 4.3 4.8 4.0 6.0 4.0 1.2-6.8 109/L
Biochemistry
Sodium 156.8 nd 156.4 150 145.9 154.1 155.7 nd 143-156 mmol/L
Potassium 2.35 nd 3.11 2.7 2.91 3.15 3.70 nd 3.5-5.2 mmol/L
nd = not determined
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anemia due to renal disease, acute blood loss (first 48-
96 hours) or anemia releated to endocrine disorders
(Couto, 2003). Anemia due to chronic or endocrine di-
sease almost never results in hematocrit below 17 or
18% (Couto, 2003) and the history and the results of
blood analysis did not support renal or endocrine dis -
order or acute blood loss. 
Neoplastic, hypoplastic or dysplastic bone marrow
disorders can result in anemia and/or other cytopenias.
To determine a final diagnosis, histopathological or cy-
tological examination of a bone marrow specimen are
warranted (Couto, 2003). In this case, cytology of a
bone marrow aspirate was performed and PRCA was
diagnosed.Various causes for bone marrow aplasia or
hypoplasia are described in cats, e.g. FeLV, immune-
mediated, drug-induced or idiopathic (Couto, 2003).
Cats with PRCA usually have a hematocrit below 15%
and CBC usually shows a severe (normocytic, normo-
chromic) non-regenerative anaemia (Couto, 2003).
Pure red cell aplasia is a form of primary immune-
mediated hemolytic anemia in dogs and cats that is
characterized by erythroid aplasia in the bone marrow
(Weiss, 2008).  In the present case, the SNAP® Combo
FIV antibody/FeLV antigen test and the PCR assay for
FeLV were performed on serum and on bone marrow
aspirate, respectively. Both test results were negative.
No drugs were administered that could have led to
bone marrow degradation. In this case, an immune-
mediated or an idiopathic condition is most likely.
PRCA with a suspected immune-mediated cause is re-
latively common in cats (Couto, 2003; Weiss, 2008).
The pathogenesis would be similar to that of immune-
mediated hemolytic anemia: the present antibodies (or
cell-mediated immunity) are directed against the
erythroid precursors (Couto, 2003).
The PCR analysis of the blood was positive for
“Candidatus M. haemominutum” DNA. This positive
result could be due to an acute or a chronic infection
(carrier state). If the cat had just carried “Candidatus
M. haemominutum”, then this agent did not cause the
clinical signs. In that case, the PRCA would be
idiopathic, because no other immune-mediated cause
of the PRCA could be found. An acute infection with
“Candidatus M. haemominutum” contributing to an
immune-mediated destruction of the red blood cell
precursors cannot be excluded. PCR assays for
Cytauxzoon felis, Ehrlichia species or Anaplasma
phago cytophilum were not performed because these
are rare infectious causes of anemia in cats, the risk of
exposure to them is geographically defined (Ishak et
al., 2007), and they have not been reported in Belgium.
Quantitative real-time PCR assays allow quantifi-
cation of hemoplasma DNA, which allows for an esti-
mation of the clinical significance of an infection
(Willi et al., 2007b). Although the real-time PCR assay
performed in this case was not a quantitative one, the
laboratory estimated on the basis of its experience that
in this sample the bacterial load was relatively high
(estimation: 100,000 bacteria/ml blood) and thus most
likely clinically relevant (Jean-Luc Pingret, Scanelis,
personal communication). This makes an acute infec-
tion with “Candidatus M. haemominutum” likely. 
In 2003, Sykes reported that an acute infection with
“Candidatus M. haemominutum” in immunocompe-
tent cats usually results in mild or absent clinical signs.
Willi et al. (2007b) added that an acute infection with
“Candidatus M. haemominutum” usually does not
lead to a significant decline of the hematocrit. There-
fore, it is questionable whether the acute infection with
“Candidatus M. haemominutum” was actually the
cause of the disease in this case. On the other hand, a
recent study showed that cats experimentally infected
with “Candidatus M. haemominutum” showed a sig-
nificant decline in hematocrit, which could indicate the
destruction of erythrocytes (Tasker et al., 2006). Coin-
fection of “Candidatus M. haemominutum” and “Can-
didatus M. turicensis” can result in a significantly
lower hematocrit compared to hemoplasma PCR-ne-
gative cats (Willi et al., 2006b). In this patient, the
blood sample was not tested for the presence of “Can-
didatus M. turicensis” DNA.
Cats are considered fully immunocompetent from
the age of 12 months. There are still substantial
changes in the immune system during the first year of
life (Day, 2007). The cat in this report became infected
at a young age, making an acute infection with “Can-
didatus M. haemominutum” a possible cause of ill-
ness. 
Clinical feline hemotropic mycoplasmosis is
mainly characterized by extravascular hemolysis
(Willi et al., 2007b). The most common hematologic
abnormalitiy is regenerative, macrocytic and normo-
chromic anemia (Willi et al., 2007b). Here, the cat had
a non-regenerative microcytic, normochromic anemia.
During hospitalization and treatment, the anemia be-
came normocytic. Microcytic, hypochromic anemia is
typically seen together with iron deficiency (Couto,
2003). In this case, the serum iron concentration was
high, a fact which was likely related to hemolysis (An-
drews and Smith, 2000). Although feline hemotropic
mycoplasmosis usually results in regenerative anemia,
some infected cats show only moderate regeneration,
for instance due to underlying retroviral infections
(Willi et al., 2007b). The patient tested negative for
FIV and FeLV. However, non-regenerative anemia has
already been described in FeLV-negative cats infected
with feline hemotropic mycoplasmosis (Sykes, 2003).
Doxycycline 5-10 mg/kg PO q12-24h for 14 to 21
days is recommended for treating infections with
“Candidatus M. haemominutum”. FeLV-negative cats
with PRCA usually respond well to immunosuppres-
sive doses of corticosteroids (4 to 8 mg/kg prednisone
PO, SID). This can be combined with chlorambucil
(Leukeran®) 20 mg/m2 PO every two weeks. Respon-
ses occur in 70 to 80% of the patients, but recovery
may take two to three months andlifelong treatment is
usually necessary (Couto, 2003). The cat in this case
was treated with doxycycline 10 mg/kg (Ronaxan® 20)
PO, SID for 24 days and prednisolone 1.75 mg/kg
(Prednisolone® 5 mg) PO, BID for ten months, and it
responded well. It is important to note that, after an
acute infection with hemoplasmas, cats can remain
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chronic carriers for months to years, even after treat-
ment with appropriate antimicrobial agents. A carrier
state after infection with “Candidatus M. haemomi-
nutum” is frequently encountered. A PCR assay to eva-
luate carrier status in this cat was not performed.
Healthy carriers constitute a source of infection for
other cats and reoccurance has been described (Willi et
al., 2007b). 
Currently, still little is known about the routes of
transmission of hemoplasmas. Blood-sucking arthro-
pods like fleas and ticks probably play an important
role in the indirect transmission of the hemoplasmas
(Messick, 2003; Willi et al., 2006a). Furthermore, a
direct transmission of hemoplasmas between cats has
also been suggested. Therefore, special emphasis
should be placed on the control of ectoparasites in the
prevention of this disease. (Willi et al., 2007a; Sykes
et al., 2008). 
CONCLUSION
The PRCA in this cat was of an immune-mediated
or idiopathic origin. Primary immune-mediated ane-
mia may be more common in cats than previously re-
cognized (Kohn et al., 2006; Weiss, 2007). The
infection with “Candidatus M. haemominutum” was
most likely acute and could have contributed to the cli-
nical signs. 
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